keyword
https://read.qxmd.com/read/38766920/a-rare-case-of-uncharacterized-autoinflammatory-disease-patient-carrying-variations-in-nlrp3-and-tnfrsf1a-genes
#21
Ozgur Can Kilinc, Konul Gayibova, Merve Ozkilinc Onen, Umut Inci Onat, Alper Bülbül, Ahmet Can Timucin, Serdal Ugurlu, Eda Tahir Turanli
Tumor necrosis factor type 1A receptor-associated periodic syndrome (TRAPS) and cryopyrin-associated autoinflammatory syndrome (CAPS) are rare monogenic autoinflammatory diseases (AIDs) mainly caused by pathogenic variations in the TNFRSF1A and NLRP3 genes, respectively. Here, we describe a unique patient presenting with symptoms overlapping both TRAPS and CAPS, without known pathogenic variants in the respective genes. The patient harbored the p.Val200Met variation in NLRP3 and the p.Ser226Cys variation in TNFRSF1A, prompting us to delve deeper into the functional analysis due to conflicting or inconclusive pathogenicity interpretations of the variants across various databases...
May 20, 2024: American Journal of Medical Genetics. Part A
https://read.qxmd.com/read/38766855/participation-of-suicide-gene-extracellular-vesicles-in-metastasis-prevention
#22
REVIEW
Dajana Vanova, Michal Andrezal, Jana Jakubechova, Ursula Altanerova, Cestmir Altaner
The incidence of distant metastases is associated with most cancer-related mortalities. Extracellular vesicles (EVs), secreted from tumors and cancer-associated fibroblasts, are involved in the metastatic process mediating their organotropism through their involvement in the pre-metastatic niche formation. We have been developing suicide gene therapy mediated by EVs secreted from mesenchymal stem/ stromal cells, tumor cells, and cancer-associated fibroblasts. Suicide gene EVs conjugated with prodrug are tumor tropic, penetrate tumor cells, and kill them by intracellular conversion of nontoxic prodrug to an efficient anti-cancer drug...
April 2024: Neoplasma
https://read.qxmd.com/read/38766851/can-hypoxia-marker-carbonic-anhydrase-ix-serve-as-a-potential-new-diagnostic-marker-and-therapeutic-target-of-non-small-cell-lung-cancer
#23
REVIEW
Silvia Fecikova, Lucia Csaderova, Petra Belvoncikova, Barbora Puzderova, Kamila Bernatova, Tomas Talac, Jaromir Pastorek, Monika Barathova
Lung cancer represents the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is a molecularly heterogeneous disease with intratumoral heterogeneity and a significant mutational burden associated with clinical outcome. Tumor microenvironment (TME) plays a fundamental role in the initiation and progression of primary de novo lung cancer and significantly influences the response of tumor cells to therapy. Hypoxia, an integral part of the tumor microenvironment and a serious clinical phenomenon, is associated with increased genetic instability and a more aggressive phenotype of NSCLC, which correlates with the risk of metastasis...
April 2024: Neoplasma
https://read.qxmd.com/read/38766832/limning-of-hif-2-and-hif-3-in-the-tumor-microenvironment-developing-concepts-for-the-treatment-of-hypoxic-cancer
#24
JOURNAL ARTICLE
Suman Kumar Ray, Sukhes Mukherjee
Hypoxia, characterized by insufficient oxygen supply to tissues, is a significant factor in tumor growth and resistance to treatment. The hypoxia-inducible factor (HIF) signaling pathway is activated when oxygen levels decline, influencing cell activities and promoting tumor progression. HIF-1α and HIF-2α are the main targets for therapeutic intervention in tumors. Nevertheless, the significance of HIF-2α is often overlooked. This review examines the physiological role of HIF-2α in tumor growth and its involvement in tumor growth...
May 17, 2024: Current Molecular Medicine
https://read.qxmd.com/read/38766820/the-cross-talk-of-non-coding-rnas-and-inflammation-in-human-cancer
#25
JOURNAL ARTICLE
Jiayi Li, Xiaoyong Lei, Xiaoyan Yang
Despite advanced clinical treatment, the mortality rate of cancer patients is high. Recent studies have linked the development of cancer to inflammation. Many cancers are exacerbated by the emergence of inflammatory responses, and non-coding RNAs play an important role in inflammation. Non-coding RNAs include microRNAs, circular RNAs, long-chain noncoding RNAs, etc. The non-coding RNA regulatory network composed of microRNAs, circular RNAs and long-chain non-coding RNAs is involved in the regulatory process of multiple gene expression...
May 17, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38766795/application-and-prognostic-relevance-of-cd34-detection-in-immunophenotyping-of-pediatric-acute-b-lymphoblastic-leukemia
#26
JOURNAL ARTICLE
W Zha, Y Yuan, T Yang, L-J Zhu, W-Y Kong, J-J Zhuo
OBJECTIVE: We aimed to investigate the application of CD34 detection in immunophenotypic discrimination and its prognostic relevance in children with acute B-lymphoblastic leukemia (B-ALL). PATIENTS AND METHODS: A retrospective analysis was conducted on clinical follow-up data of 105 children with newly diagnosed B-ALL treated at our hospital from January 2022 to December 2023. Based on the expression of CD34 in the bone marrow, patients were divided into a CD34 positive group (positive cells ≥10%) and a CD34 negative group (positive cells <10%)...
May 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38766697/prior-immune-checkpoint-inhibitors-may-enhance-severe-hypersensitivity-related-to-selpercatinib-in-ret-fusion-gene-positive-lung-cancer
#27
JOURNAL ARTICLE
Kosuke Hashimoto, Kyoichi Kaira, Hisao Imai, Ayako Shiono, Hiroshi Kagamu
Selpercatinib, a tyrosine kinase inhibitor approved for RET-fusion gene-positive lung cancer, can induce hypersensitivity, potentially exacerbated by prior immune checkpoint inhibitor (ICI) therapy. We present a case of severe toxicity following selpercatinib treatment in a 58-year-old female with lung adenocarcinoma, refractory to previous treatments including pembrolizumab. Symptoms included fever, rash, and multiorgan failure indicative of grade 4 hypersensitivity. Treatment involved platelet transfusion, heparin therapy, and prednisolone, leading to improvement upon selpercatinib cessation...
May 20, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38766661/strategies-for-improved-pdna-loading-and-protection-using-cationic-and-neutral-lnps-with-industrial-scalability-potential-using-microfluidic-technology
#28
JOURNAL ARTICLE
Ilaria Ottonelli, Elisa Adani, Andrea Bighinati, Sabrina Cuoghi, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi, Valeria Marigo, Jason Thomas Duskey
PURPOSE: In recent years, microfluidic technologies have become mainstream in producing gene therapy nanomedicines (NMeds) following the Covid-19 vaccine; however, extensive optimizations are needed for each NMed type and genetic material. This article strives to improve LNPs for pDNA loading, protection, and delivery, while minimizing toxicity. METHODS: The microfluidic technique was optimized to form cationic or neutral LNPs to load pDNA. Classical "post-formulation" DNA addition vs "pre" addition in the aqueous phase were compared...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38766548/addressing-cortex-dysregulation-in-youth-through-brain-health-check-coaching-and-prophylactic-brain-development
#29
JOURNAL ARTICLE
Kenneth Blum, Eric R Braverman, Mark S Gold, Catherine A Dennen, David Baron, Panayotis K Thanos, Colin Hanna, Igor Elman, Marjorie C Gondre-Lewis, J Wesson Ashford, Andrew Newberg, Margaret A Madigan, Nicole Jafari, Foojan Zeine, Keerthy Sunder, John Giordano, Debmayla Barh, Ashim Gupta, Paul Carney, Abdalla Bowirrat, Rajendra D Badgaiyan
The Carter Center has estimated that the addiction crisis in the United States (US), if continues to worsen at the same rate, may cost the country approximately 16 trillion dollars by 2030. In recent years, the well-being of youth has been compromised by not only the coronavirus disease 2019 pandemic but also the alarming global opioid crisis, particularly in the US. Each year, deadly opioid drugs claim hundreds of thousands of lives, contributing to an ever-rising death toll. In addition, maternal usage of opioids and other drugs during pregnancy could compromise the neurodevelopment of children...
April 30, 2024: INNOSC Theranostics Pharmacol Sci
https://read.qxmd.com/read/38766527/enhanced-transgene-expression-from-single-stranded-aav-vectors-in-human-cells-in%C3%A2-vitro-and-in-murine-hepatocytes-in%C3%A2-vivo
#30
JOURNAL ARTICLE
Yuan Lu, Chen Ling, Jakob Shoti, Hua Yang, Aneesha Nath, Geoffrey D Keeler, Keyun Qing, Arun Srivastava
We identified that distal 10 nucleotides in the D-sequence in AAV2 inverted terminal repeat (ITR) share partial sequence homology to 1/2 binding site of glucocorticoid receptor-binding element (GRE). Here, we describe that (1) purified GR binds to AAV2 D-sequence, and the D-sequence competes with GR binding to its cognate binding site; (2) dexamethasone-mediated activation of GR pathway significantly increases the transduction efficiency of AAV2 vectors in human cells; (3) human osteosarcoma cells, U2OS, which lack expression of GR, are poorly transduced by AAV2 vectors, but stable transfection with a GR expression plasmid restores vector-mediated transgene expression; (4) replacement of the distal 10 nucleotides in the D-sequence of the AAV2 ITR with a full-length GRE consensus sequence significantly enhances transgene expression in human cells in vitro and in murine hepatocytes in vivo ; and (5) none of the ITRs in AAV1, AAV3, AAV4, AAV5, and AAV6 genomes contains the GRE 1/2 binding site, and insertion of a full-length GRE consensus sequence in the AAV6-ITR also significantly enhances transgene expression from AAV6 vectors, both in vitro and in vivo ...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38766526/engineering-miniature-crispr-cas-un1cas12f1-for-efficient-base-editing
#31
JOURNAL ARTICLE
Yueer Hu, Linxiao Han, Qiqin Mo, Zengming Du, Wei Jiang, Xia Wu, Jing Zheng, Xiao Xiao, Yadong Sun, Hanhui Ma
Adeno-associated virus (AAV) is a relatively safe and efficient vector for gene therapy. However, due to its 4.7-kb limit of cargo, SpCas9-mediated base editors cannot be packaged into a single AAV vector, which hinders their clinical application. The development of efficient miniature base editors becomes an urgent need. Un1Cas12f1 is a class II V-F-type CRISPR-Cas protein with only 529 amino acids. Although Un1Cas12f1 has been engineered to be a base editor in mammalian cells, the base-editing efficiency is less than 10%, which limits its therapeutic applications...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38766525/crispr-based-editing-strategies-to-rectify-eya1-complex-genomic-rearrangement-linked-to-haploinsufficiency
#32
JOURNAL ARTICLE
Hwalin Yi, Yejin Yun, Won Hoon Choi, Hye-Yeon Hwang, Ju Hyuen Cha, Heeyoung Seok, Jae-Jin Song, Jun Ho Lee, Sang-Yeon Lee, Daesik Kim
Pathogenic structure variations (SVs) are associated with various types of cancer and rare genetic diseases. Recent studies have used Cas9 nuclease with paired guide RNAs (gRNAs) to generate targeted chromosomal rearrangements, focusing on producing fusion proteins that cause cancer, whereas research on precision genome editing for rectifying SVs is limited. In this study, we identified a novel complex genomic rearrangement (CGR), specifically an EYA1 inversion with a deletion, implicated in branchio-oto-renal/branchio-oto syndrome...
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38766524/a-cystic-fibrosis-gene-editing-approach-that-is-on-target
#33
Joseph J Porter, John D Lueck
No abstract text is available yet for this article.
June 11, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38766487/arsenic-disulfide-promoted-the-demethylation-of-ptpl1-in-diffuse-large-b-cell-lymphoma-cells
#34
JOURNAL ARTICLE
Chen Chen, Ling Wang, Yan Liu, Shenghong Du, Qingliang Teng
BACKGROUND: Promoter hypermethylation of the tumor suppressor gene is one of the well-studied causes of cancer development. The drugs that reverse the process by driving demethylation could be a candidate for anticancer therapy. This study was designed to investigate the effects of arsenic disulfide on PTPL1 methylation in diffuse large B cell lymphoma (DLBCL). METHODS: We knocked down the expression of PTPL1 in two DLBCL cell lines ( i.e. , DB and SU-DHL-4 cells) using siRNA...
2024: PeerJ
https://read.qxmd.com/read/38766314/differentiating-monogenic-and-syndromic-obesities-from-polygenic-obesity-assessment-diagnosis-and-management
#35
REVIEW
Angela K Fitch, Sonali Malhotra, Rushika Conroy
BACKGROUND: Obesity is a multifactorial neurohormonal disease that results from dysfunction within energy regulation pathways and is associated with increased morbidity, mortality, and reduced quality of life. The most common form is polygenic obesity, which results from interactions between multiple gene variants and environmental factors. Highly penetrant monogenic and syndromic obesities result from rare genetic variants with minimal environmental influence and can be differentiated from polygenic obesity depending on key symptoms, including hyperphagia; early-onset, severe obesity; and suboptimal responses to nontargeted therapies...
September 2024: Obes Pillars
https://read.qxmd.com/read/38766272/genome-editing-and-kidney-health
#36
REVIEW
Nadia Tavakolidakhrabadi, Francesco Aulicino, Carl J May, Moin A Saleem, Imre Berger, Gavin I Welsh
Genome editing technologies, clustered regularly interspaced short palindromic repeats (CRISPR)-Cas in particular, have revolutionized the field of genetic engineering, providing promising avenues for treating various genetic diseases. Chronic kidney disease (CKD), a significant health concern affecting millions of individuals worldwide, can arise from either monogenic or polygenic mutations. With recent advancements in genomic sequencing, valuable insights into disease-causing mutations can be obtained, allowing for the development of new treatments for these genetic disorders...
May 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38766226/mek1-2-and-erk1-2-mediated-lung-endothelial-injury-and-altered-hemostasis-promote-diffuse-alveolar-hemorrhage-in-murine-lupus
#37
Haoyang Zhuang, Shuhong Han, Neil S Harris, Westley H Reeves
OBJECTIVE: About 3% of lupus patients develop severe diffuse alveolar hemorrhage (DAH) with pulmonary vasculitis. B6 mice with pristane-induced lupus also develop DAH, but BALB/c mice are resistant. DAH is independent of TLR signaling and other inflammatory pathways. This study examined the role of the mitogen-activated protein kinase pathway (MEK1/2-ERK1/2, JNK, p38). METHODS: B6 and BALB/c mice were treated with pristane ± inhibitors of MEK1/2 (trametinib/GSK1120212, "GSK"), ERK1/2 (SCH772984, "SCH"), JNK, or p38...
May 10, 2024: bioRxiv
https://read.qxmd.com/read/38766212/gene-amplification-of-mediator-subunit-30-redirects-the-myc-transcriptional-program-and-oncogenesis
#38
Chunyu Jin, Linjie Zhao, Guofeng Zhao, Yujia Liu, Wubin Ma, Shenghong Ma, Likun Yao, Yuan Liu, Qiulian Wu, Huairui Yuan, Kailin Yang, Kenneth Ohgi, Jeremy N Rich, Michael G Rosenfeld
Understanding the molecular mechanisms underlying tumorigenesis is crucial for developing effective cancer therapies. Here, we investigate the co-amplification of MED30 and MYC across diverse cancer types and its impact on oncogenic transcriptional programs. Transcriptional profiling of MYC and MED30 single or both overexpression/amplification revealed the over amount of MED30 lead MYC to a new transcriptional program that associate with poor prognosis. Mechanistically, MED30 overexpression/amplification recruits other Mediator components and binding of MYC to a small subset of novel genomic regulatory sites, changing the epigenetic marks and inducing the formation of new enhancers, which drive the expression of target genes crucial for cancer progression...
May 6, 2024: Research Square
https://read.qxmd.com/read/38766195/microbiota-and-metabolic-adaptation-shape-staphylococcus-aureus-virulence-and-antimicrobial-resistance-during-intestinal-colonization
#39
Chunyi Zhou, Miranda B Pawline, Alejandro Pironti, Sabrina M Morales, Andrew I Perault, Robert J Ulrich, Magdalena Podkowik, Alannah Lejeune, Ashley DuMont, François-Xavier Stubbe, Aryeh Korman, Drew R Jones, Jonas Schluter, Anthony R Richardson, Paul D Fey, Karl Drlica, Ken Cadwell, Victor J Torres, Bo Shopsin
UNLABELLED: Depletion of microbiota increases susceptibility to gastrointestinal colonization and subsequent infection by opportunistic pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). How the absence of gut microbiota impacts the evolution of MRSA is unknown. The present report used germ-free mice to investigate the evolutionary dynamics of MRSA in the absence of gut microbiota. Through genomic analyses and competition assays, we found that MRSA adapts to the microbiota-free gut through sequential genetic mutations and structural changes that enhance fitness...
May 11, 2024: bioRxiv
https://read.qxmd.com/read/38766192/tumor-microenvironmental-determinants-of-high-risk-dcis-progression
#40
Alexander Borowsky, Alexa Glencer, Kirithiga Ramalingam, Nicole Schindler, Hidetoshi Mori, Parchi Ghule, Kyra Lee, Daniela Nachmanson, Adam Officer, Olivier Harismendy, Janet Stein, Gary Stein, Mark Evans, Donald Weaver, Christina Yau, Gillian Hirst, Michael Campbell, Laura Esserman
Ductal carcinoma in situ (DCIS) constitutes an array of morphologically recognized intraductal neoplasms in the mammary ductal tree defined by an increased risk for subsequent invasive carcinomas at or near the site of biopsy detection. However, only 15-45% of untreated DCIS cases progress to invasive cancer, so understanding mechanisms that prevent progression is key to avoid overtreatment and provides a basis for alternative therapies and prevention. This study was designed to characterize the tumor microenvironment and molecular profile of high-risk DCIS that grew to a large size but remained as DCIS...
May 9, 2024: Research Square
keyword
keyword
3703
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.